Overview
- 6 inspections across 5 sites are on record.
- 15 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2016-09-26.
At a glance
Inspections
6
Sites
5
Observations
15
Career since
Jul 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Fisiopharma Srl | 26 Sep 2016 | Human Drugs | |
| Gilead Sciences Inc | 26 Sep 2014 | Human Drugs | |
| Gilead Sciences Inc | 7 Aug 2013 | Human Drugs | |
| Genentech, Inc. | 23 May 2013 | Human Drugs | |
| K.C. Pharmaceuticals, Inc | 14 Feb 2011 | View 483 → |
Sites inspected
Fisiopharma SrlPalomonte, Italy1 insp.
Gilead Sciences IncSan Dimas, United States2 insp.
Genentech, Inc.Oceanside, United States1 insp.
K.C. Pharmaceuticals, IncPomona, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Jennifer M Gogley4 shared
Caryn M Mcnab2 shared
Jason R Caballero1 shared
Matthew J Johnson1 shared
Virgilio F Pacio1 shared
Sonya L Karsik1 shared
Uttaniti Limchumroon1 shared
Pal S Mayasandra1 shared
John A Gonzalez1 shared
Full investigator report
Get the verbatim findings behind Jamie M Du's 15 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site